Skip to main content
. 2007 Mar 28;64(1):75–82. doi: 10.1111/j.1365-2125.2007.02880.x

Table 2.

Pharmcokinetic data of CNS 5161 (mean ± SD) in the different dosage cohorts

Cohort 1 125 µg 12 Cohort 2 250 µg 12 Cohort 3 500 µg 12
t1/2 (h) 8.2 ± 3.4 8.7 ± 3.7 8.3 ± 1.6
Cmax (pg ml−1) 331.6 ± 204.9 876.0 ± 582.0 1056.7 ± 484.0
AUC0−24 h (h pg−1 ml−1 µg−1) 1772.3 ± 565.6 4348.2 ± 915.9 7017.3 ± 2093.3